Sep 04, 2014
727:722
For every 722 shares held, investors received 727. The price per share adjusted from $41.05 to $40.77.
The split itself did not change the total investment value.
GenMont Biotech, Inc. (TWSE:3164) operates in the Pharmaceuticals: other industry.
GenMont Biotech, Inc. company overviewGenMont Biotech, Inc.'s most recent stock split was on September 4, 2014. It was a 727-for-722 forward split, so shareholders received 727 shares for every 722 they held.
GenMont Biotech, Inc. (TWSE:3164) has split its stock 3 times: a 53-for-52 split on November 6, 2006, a 11-for-10 split on June 15, 2010, and a 727-for-722 split on September 4, 2014.
GenMont Biotech, Inc. has split its stock 3 times. This history records 3 forward splits between November 6, 2006 and September 4, 2014.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In GenMont Biotech, Inc.'s 727-for-722 split on September 4, 2014, every 722 shares became 727 shares.
GenMont Biotech, Inc. has not announced a new split in our records. Its most recent split was on September 4, 2014, 12 years ago. Companies announce splits in advance, and any new TWSE:3164 split will appear on this page.
Already premium?